Factors associated with C-reactive protein at the early stage of acute myocardial infarction in men

Cardiology Journal

Volumn 16, Issue 1, 2009, Pages 36-42

  Piestrzeniewicz, Katarzyna ^a   Łuczak, Katarzyna ^a   Goch, Jan Henryk ^a  

^a 1st Clinic of Cardiology   (Poland)

Author keywords

Adipokines; C reactive protein; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ADIPOCYTOKINE; ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; GLUCOSE; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEPTIN; NITRATE; RESISTIN;

ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OBESITY; POSTOPERATIVE THROMBOSIS; PREDICTION; PROTEIN BLOOD LEVEL; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION; WAIST CIRCUMFERENCE;

ADIPONECTIN; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; HUMANS; LEPTIN; LIPIDS; LOGISTIC MODELS; MALE; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RESISTIN; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; UP-REGULATION; WAIST CIRCUMFERENCE;

EID: 60849131888     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses, 2004; 62: 499-506.
2. Liuzzo G, Santamaria M, Biasucci LM et al. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. J Am Coll Cardiol, 2007; 49: 185-194.
3. Verma S, Badiwala MV, Weisel RD et al. C-reactive protein activates the nuclear factor-kappa B signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis. J Thorac Cardiovasc Surg, 2003; 126: 1886-1891.
4. Trayhurn P. Endocrine and signalling role of adipose tissue: New perspectives on fat. Acta Physiol Scand, 2005; 84: 285-293.
5. Bullo M, Garcia-Lorda P, Megias I, Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res, 2003; 11: 525-531.
6. Wärnberg J, Nova E, Moreno LA et al. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: The AVENA Study. Am J Clin Nutr, 2006; 84: 505-512.
7. Benderly M, Haim M, Boyko V et al. C-Reactive protein distribution and correlates among men and women with chronic coronary heart disease. Cardiology, 2007; 107: 345-353.
8. Vendrell J, Broch M, Vilarrasa N et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: Relationships in obesity. Obes Res, 2004; 12: 962-971.
9. Aquilante CL, Kosmiski LA, Knutsen SD, Zineh I. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults. Metabolism, 2008; 57: 494-501.
10. Kunnari A, Ukkola O, Päivänsalo M, Kesäniemi YA. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J Clin Endocrinol Metab, 2006; 91: 2755-2760.
11. Shamsuzzaman AS, Winnicki M, Wolk R et al. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation, 2004; 109: 2181-2185.
12. Matsushita K, Yatsuya H, Tamakoshi K et al. Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men. Atherosclerosis, 2006; 188: 184-189.
13. Marfella R, Siniscalchi M, Esposito K et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care, 2003; 26: 3129-3135.
14. Tomoda H, Aoki N. Prognostic value of C-reactive protein levels within 6 hours after the onset of acute myocardial infarction. Am Heart J, 2000; 140: 324-328.
15. Yip HK, Wu CJ, Chang HW et al. Levels and values of serum high-sensitivity C-reactive protein within 6 hours after the onset of acute myocardial infarction. Chest, 2004; 126: 1417-1422.
16. Celik T, Iyisoy A, Kursaklioglu H et al. The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction. Coron Artery Dis, 2005; 16: 293-299.
17. Piestrzeniewicz K, Łuczak K, Komorowski J, Jankiewicz-Wika J, Goch JH. Relation of C-reactive protein to obesity, adipose tissue hormones and cardiovascular risk factors in men treated with early percutaneous intervention in course of acute myocardial infarction. Neuro Endocrinol Lett, 2007; 28: 427-432.
18. Oswald GA, Smith CCT, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ, 1986; 293: 917-922.
19. Ceriello A. Acute hyperglycaemia: a "new" risk factor during myocardial infarction. Eur Heart J 2005; 26: 328-331.
20. Helmersson J, Vessby B, Larsson A, Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation, 2004; 109: 1729-1734.
21. Henareh L, Jogestrand T, Agewall S. Glucose intolerance is associated with C-reactive protein and intima-media anatomy of the common carotid artery in patients with coronary heart disease. Diabet Med, 2005; 22: 1212-1217.
22. de Rekeneire N, Peila R, Ding J et al. Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diabetes Care 2006; 29: 1902-1908.
23. Gustavsson CG, Agardh CD. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range. Eur Heart J, 2004; 25: 2120-2124,
24. Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol, 2008; 45: 1-16.
25. Schillinger M, Exner M, Amighi J et al. Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation, 2003; 108: 2323-2328.
26. Aggarwal A, Schneider DJ, Sobel BE, Dauerman HL. Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting. Am J Cardiol, 2003; 92: 924-929.
27. Pilz S, Weihrauch G, Seelhorst U et al. Implications of resistin plasma levels in subjects undergoing coronary angiography. Clin Endocrinol (Oxford), 2007; 66: 380-386.
28. Hoefle G, Saely CH, Risch L et al. Relationship between the adipose-tissue hormone resistin and coronary artery disease. Clin Chim Acta, 2007; 386: 1-6.
29. Verma S, Li SH, Wang CH et al. Resistin promotes endothelial cell activation: Further evidence of adipokine-endothelial interaction. Circulation, 2003; 108: 736-740.
30. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun, 2003; 309: 286-290.
31. Yan GT, Xue H, Lin J, Hao XH, Zhang K, Wang LH. Correlation analysis of increase in serum level of leptin with that of C-reactive protein, troponin T and endothelin in patients with acute myocardial infarction. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2005; 17: 530-532.
32. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta, 2007; 380: 24-30.
33. Nishida M, Moriyama T, Ishii K et al. Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis. Clin Chim Acta, 2007; 384: 99-104.
34. Saely CH, Risch L, Hoefle G, et al. Low serum adiponectin is independently associated with both the metabolic syndrome and angiographically determined coronary atherosclerosis. Clin Chim Acta, 2007; 383: 97-102.
35. Kojima S, Funahashi T, Maruyoshi H et al. Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma. Thromb Res, 2005; 115: 483-490.
36. Sutherland JP, McKinley B, Eckel RH. The metabolic syndrome and inflammation. Metab Syndr Relat Disord, 2004; 2: 82-104.
37. O'Loughlin J, Lambert M, Karp I et al. Association between cigarette smoking and C-reactive protein in a representative, population-based sample of adolescents. Nicotine Tob Res, 2008; 10: 525-532.